Trial Profile
BIOTRONIK - Safety and Performance Registry for an all-comers patient population with the Limus Eluting Orsiro Stent System Within daily clinical practice - III (UK & Ireland Satellite)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BIOFLOW III
- 29 Jan 2016 New trial record